21+ hour, 59+ min ago   (847+ words) AstraZeneca just quietly flexed on the market. Is this pharma giant a low-key must-have in your portfolio or just boomer stock cosplay? Real talk, here is what the numbers and hype actually say. The internet is not exactly losing it…...

1+ week, 4+ day ago   (907+ words) Everyone's suddenly watching News Corp Class B, but is NWS a quiet killer stock or just legacy-media cosplay? Here's the real talk on hype, risk, and whether you should even touch it. While everyone chases meme coins and AI moonshots,…...